The abnormalities in glucagon secretion in T2DM include both loss of adequate suppression under hyperglycaemic conditions and insufficient release during episodes of hypoglycaemia (Cryer, 2002, 2008; Cryer et al. This evidence concerns the gene GCG and type 2 diabetes mellitus.